Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination for disease.

S Oehen1, H Hengartner, R M Zinkernagel

  • 1Laboratory for Experimental Pathology, University of Zürich, Switzerland.

Science (New York, N.Y.)
|January 11, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.

Blood cells, molecules & diseases·2017
Same author

Reactive oxygen species delay control of lymphocytic choriomeningitis virus.

Cell death and differentiation·2013
Same author

Responses to Cohn's discussion on the Zinkernagel-Hengartner 'Credo 2004'.

Scandinavian journal of immunology·2005
Same author

Port-A-Cath infections in children with cancer.

European journal of cancer (Oxford, England : 1990)·2004
Same author

On immunity against infections and vaccines: credo 2004.

Scandinavian journal of immunology·2004
Same author

Neutralizing antiviral antibody responses.

Advances in immunology·2001
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

New recombinant virus vaccines aim to balance viral spread and immune response. However, T cell-mediated immunopathology can cause disease, influenced by host genetics and vaccine specifics.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Recombinant virus vaccines expressing limited epitopes are under development.
  • These vaccines aim to alter the balance between viral spread and immune response to prevent disease.

Purpose of the Study:

  • To investigate potential adverse effects of novel peptide and recombinant vaccines.
  • To identify factors influencing vaccine-induced immunopathology.

Main Methods:

  • Analysis of infections with a noncytopathic virus.
  • Evaluation of host genetic background, infection timing and dose, and vaccine composition.

Main Results:

  • Vaccination with recombinant viruses can paradoxically cause disease under specific conditions.

Related Experiment Videos

  • Host genetic background, infection parameters, and vaccine components were identified as critical factors.

    • Conclusions:

    • T cell-mediated immunopathology is a potential risk associated with new peptide and recombinant vaccines.
    • Careful consideration of host factors and vaccine design is crucial for preventing vaccine-induced disease, particularly for vaccines targeting human immunodeficiency viruses and other pathogens.